We help pharmaceutical, biotech, and healthcare organisations translate complex clinical data into compelling, accurate, and impactful communications for healthcare professionals worldwide.
From early-phase regulatory writing to post-launch KOL engagement, we provide end-to-end support tailored to your programme.
High-quality, publication-ready manuscripts (primary manuscripts, secondary manuscripts, etc.), review articles, case reports, and healthcare content authored by experienced medical writers to the highest scientific standards.
Visually compelling and scientifically rigorous slide decks, congress abstracts, poster design, and on-site meeting support for local and international medical meetings.
Clinical study protocols (CSP), clinical study reports (CSR), investigator brochures (IB), patient narratives (e.g., patient narratives of death, patient narratives of serious adverse events, patient narratives of adverse events of special interest, etc.), protocol amendments, annual safety report (ASR), informed consent form (ICF), layperson summary, other regulatory documents, with scientific documents prepared to the standards of global health authorities.
Field-ready materials, scientific exchange tools, and strategic communication support for Medical Science Liaison (MSL) teams engaging with key opinion leaders (KOLs).
Development of educational programmes and CME-compatible content in collaboration with accredited institutes, keeping healthcare professionals at the forefront of their fields.
Integrated launch materials, branded and unbranded content, and cross-functional campaign support to ensure a strong and compliant product introduction to market.
Strategic planning and logistical support for advisory boards, expert panels, and key opinion leader (KOL) identification, contracting, and relationship management.
Transforming complex clinical trial data, biomarker findings, and outcomes research into clear, accessible visuals and infographics for diverse healthcare audiences.
The communication of scientific information is as critical as the development of the data itself. Keeping healthcare professionals up to date with medical advances is essential to improving patient care — and that is the mission at the heart of everything we do.
Formerly known as Insight Medical Communications (established 1996) and incorporated as Bingham Mayne and Smith Ltd. in 2005, we bring over three decades of experience to every project. Our network of skilled professionals brings decades of hands-on expertise across a wide range of therapeutic areas.
From the experience gained in the international healthcare arena, we understand your objectives deeply. We provide fully customised solutions, working as a true extension of your team from concept to delivery.
We are not a CME accredited company, but partner with accredited institutes to develop compliant CME-qualifying content for our clients.
Originally established as Insight Medical Communications.
Became Bingham Mayne and Smith Ltd.
A trusted partner to pharmaceutical, biotech, and healthcare organisations across international markets, with deep expertise in translating science into action.
Our teams bring deep clinical knowledge across a broad spectrum of disease areas and specialties.
Whether you have a specific brief or want to explore how we can support you, our team is ready to listen and advise.
